Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 24, Issue 3, 2009, Pages 892-899

  Tsuboi, Nobuo ^a   Kawamura, Tetsuya ^a   Ishii, Takeo ^a   Utsunomiya, Yasunori ^a   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glomerular density; Glomerular hypertrophy; IgA nephropathy; Nephron number; Renal biopsy

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLOMERULAR STRUCTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; NEPHRON; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIOPSY; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ORGAN SIZE; TIME FACTORS; YOUNG ADULT;

EID: 60749097160     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn572     Document Type: Article

References (32)

1. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088-2097
2. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196
3. Feehally J. Predicting prognosis in IgA nephropathy. Am J Kidney Dis 2001; 38: 881-883
4. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
5. Szeto CC, Lai FM, To K et al. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001; 110: 434-437
6. Haas M. Histological subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842
7. Tomino Y, Sakai H. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 2003; 7: 93-97
8. Lee HS, Lee MS, Lee SM et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting HS Lee's glomerular grading system. Nephrol Dial Transplant 2005; 20: 342-348
9. Remuzzi G, Benigni A, Remuzzi A. Mechanism of progression and regression of renal lesion of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296
10. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992; 232: 194-201
11. Hoy WE, Douglas-Denton RN, Hughson MD et al. A stereological study of glomerular number and volume: preliminary findings in multiracial study of kidneys at autopsy. Kidney Int 2003; 83: S32-S37
12. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249: F324-F337
13. Shimamura T, Morrison AB. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 1975; 79: 95-106
14. Novick AC, Gephardt G, Guz B et al. Long-termfollow-up after partial removal of a solitary kidney. N Engl J Med 1991; 325: 1058-1062
15. Abdi R, Slakey D, Kittur D et al. Heterogeneity of glomerular size in normal donor kidneys. Impact of race. Am J Kidney Dis 1998; 43-46
16. Schmidt K, Pesce C, Liu Q et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol 1992; 3: 229-235
17. Young RJ, Hoy WE, Kincaid-Smith P et al. Glomerular size and glomerulosclerosis in Australian aborigines. Am J Kidney Dis 2000; 36: 481-489
18. Tateno S, Kobayashi Y. Quantitative analysis of mesangial areas in serial biopsied patients with IgA nephropathy. Nephron 1987; 46: 28-33
19. Yoshikawa N, Iijima K, Matsuyama S et al. Repeat renal biopsy in children with IgA nephropathy. Clin Nephrol 1990; 33: 160-167
20. Hotta O, Furuta T, Chiba S et al. Regression of IgA nephropathy: a repeat biopsy study. Am J Kidney Dis 2002; 39: 493-502
21. McIntyre CW, Fluck RJ, Lambie SH. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment. Clin Nephrol 2001; 56: 193-198
22. Zanndi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006; 47: 1-7
23. Keller G, Zimmer G, Mall G et al. Nephron number in patients with primary hypertension. N Engl J Med 2003; 348: 101-108
24. Baker DJ, Osmond C. Low birth weight and hypertension. BMJ 1988; 297: 134-135
25. Hoy HY, Rees M, Kile E et al. Low birth weight and renal disease in Australian aborigines. Lancet 1998; 352: 1826-1827
26. Rossing P, Tarnow L, Nielsen FS et al. Low birth weight. A risk factor for development of diabetic nephropathy? Diabetes 1995; 44: 1405-1407
27. Duncan RC, Bass PS, Garrett PJ et al. Weight at birth and other factors influencing progression of idiopathic membranous nephropathy. Nephrol Dial Transplant 1994; 9: 875
28. Zidar N, Cavic MA, Kenda RB et al. Effect of intrauterine growth retardation on the clinical course and prognosis of IgA glomerulonephritis in children. Nephron 1998; 79: 28-32
29. Celsi G, Kistner A, Aizman R et al. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 1998; 44: 317-322
30. Vehaskari VM, Aviles DH, Manning J. Prenatal programming of adult hypertension in the rat. Kidney Int 2001; 59: 238-245
31. Olson JL, Hostetter TH, Rennke HG et al. Mechanism of altered glomerular permselectivity and progressive glomerulosclerosis following extensive ablation of renal mass. Kidney Int 1982; 22: 112-126
32. Olson JL, Heptinstall RH. Nonimmunologic mechanisms of glomerular injury. Lab Invest 1988; 59: 564-578